Walleye Capital
NERV icon

Walleye Capital’s Minerva Neurosciences NERV Stock Holding History

Walleye Capital’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Buy
+53,897
New +$292K ﹤0.01% 3177
2021
Q2 		– Sell
-2,078
Closed -$49K – 1456
2021
Q1 		$49K Sell
2,078
-5,405
-72% -$135K ﹤0.01% 1067
2020
Q4 		$140K Buy
+7,483
New +$188K 0.01% 777

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Walleye Capital's NERV Position: Q2 2026 in Review

Walleye Capital opened a new position in Minerva Neurosciences (NERV) in Q2 2026: 53,897 shares worth $299K. The stake represents ﹤0.01% of the portfolio and ranks #3177 among its holdings. This is a return to the name: Walleye Capital previously reported a position in NERV as recently as Q1 2021.

Walleye Capital first reported a position in NERV in Q4 2020 and has held it in 3 quarters since. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Walleye Capital held 53,897 shares of Minerva Neurosciences worth $299K as of Q2 2026.
  • Minerva Neurosciences was a new Walleye Capital position in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3177 holding.
  • Walleye Capital first reported a position in Minerva Neurosciences in Q4 2020 and has held it in 3 quarters since.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.